The Experiences of Patients Living With Malignant Pleural Effusions

Gloucestershire Hospitals NHS Foundation Trust

Status: Unknown

Conditions: Malignant Pleural Effusion

Study type: Observational

Funder types: Other

Identifiers

NCT03235999

16/009/GHT

Details and patient eligibility

About

Up to 20 patients with malignant pleural effusions will be interviewed about their experiences of having this condition and its management.

Enrollment: 20 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Adults diagnosed with a malignant pleural effusion
2. Has undergone either talc pleurodesis or IPC
3. Have signed a consent form prior to entering the study
4. Life expectancy > 6 weeks based on LENT guidelines (Low/Moderate risk group) - The LENT score calculation assigns 0 (<1500 IU/L) or 1 (>1500 IU/L) for pleural fluid LDH level; 0 to 3 points for matching ECOG performance scores (3 and 4 are combined); 0 (<9) or 1 (>9) for neutrophil-to-lymphocyte ratio; and 0 (lowest risk), 1 (moderate risk), or 3 (highest risk) for tumor type.

Exclusion criteria

1. Any patient who is unable to understand sufficient English to take part in the semi-structured interviews
2. Weakness or fatigue sufficient so that the patient is unable to take part in the interviews

Trial design

20 participants in 2 patient groups

Talc pleurodesis

Description:

Up to 10 patients who have had talc pleurodesis

IPC

Description:

Up to 10 patients who have had indwelling pleural catheters (IPC)